These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12576235)

  • 1. Genetic variations and humoral immune responses to myelin oligodendroglia glycoprotein in adult phenotypes of X-linked adrenoleukodystrophy.
    Schmidt S; Marrosu GM; Kölsch H; Haase CG; Ferenczik S; Sokolowski P; Köhler W; Schmidt M; Papassotiropoulos A; Heun R; Grosse-Wilde H; Klockgether T
    J Neuroimmunol; 2003 Feb; 135(1-2):148-53. PubMed ID: 12576235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin oligodendrocyte glycoprotein (MOG) polymorphisms and adrenoleukodystrophy.
    Gomez-Lira M; Marzari MG; Uziel G; Pignatti P; Rizzuto N; Salviati A
    J Neuroimmunol; 2000 Nov; 111(1-2):245-7. PubMed ID: 11063846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.
    Lutterotti A; Reindl M; Gassner C; Poustka K; Schanda K; Deisenhammer F; Berger T
    J Neuroimmunol; 2002 Oct; 131(1-2):201-7. PubMed ID: 12458053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis.
    Schmidt S; Haase CG; Bezman L; Moser H; Schmidt M; Köhler W; Linington C; Klockgether T
    J Neuroimmunol; 2001 Sep; 119(1):88-94. PubMed ID: 11525804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic tri- and tetranucleotide repeats in exons 1 and 8 of the myelin oligodendrocyte glycoprotein (MOG) gene.
    Malfroy L; Viratelle C; Coppin H; Borot N; Roth MP
    Hum Genet; 1995 Dec; 96(6):737-8. PubMed ID: 8522338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of X-linked adrenoleukodystrophy with HLA DRB1 alleles.
    Berger J; Bernheimer H; Faé I; Braun A; Roscher A; Molzer B; Fischer G
    Biochem Biophys Res Commun; 1995 Nov; 216(2):447-51. PubMed ID: 7488132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage study of polymorphisms in the gene for myelin oligodendrocyte glycoprotein located on chromosome 6p and attention deficit hyperactivity disorder.
    Barr CL; Shulman R; Wigg K; Schachar R; Tannock R; Roberts W; Malone M; Kennedy JL
    Am J Med Genet; 2001 Apr; 105(3):250-4. PubMed ID: 11353444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
    Weissert R; Kuhle J; de Graaf KL; Wienhold W; Herrmann MM; Müller C; Forsthuber TG; Wiesmüller KH; Melms A
    J Immunol; 2002 Jul; 169(1):548-56. PubMed ID: 12077287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy.
    D'Alfonso S; Bolognesi E; Guerini FR; Barizzone N; Bocca S; Ferrante D; Castelli L; Bergamaschi L; Agliardi C; Ferrante P; Naldi P; Leone M; Caputo D; Ballerini C; Salvetti M; Galimberti D; Massacesi L; Trojano M; Momigliano-Richiardi P
    Genes Immun; 2008 Jan; 9(1):7-15. PubMed ID: 17928868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis.
    Khare M; Rodriguez M; David CS
    Int Immunol; 2003 Apr; 15(4):535-46. PubMed ID: 12663683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.
    Raddassi K; Kent SC; Yang J; Bourcier K; Bradshaw EM; Seyfert-Margolis V; Nepom GT; Kwok WW; Hafler DA
    J Immunol; 2011 Jul; 187(2):1039-46. PubMed ID: 21653833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder.
    Zai G; Bezchlibnyk YB; Richter MA; Arnold P; Burroughs E; Barr CL; Kennedy JL
    Am J Med Genet B Neuropsychiatr Genet; 2004 Aug; 129B(1):64-8. PubMed ID: 15274043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
    Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
    Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico study of the association of the HLA-A*31:01 allele (human leucocyte antigen allele 31:01) with neuroantigenic epitopes of PLP (proteolipid protein), MBP (myelin basic protein) and MOG proteins (myelin oligodendrocyte glycoprotein) for studying the multiple sclerosis disease pathogenesis.
    Mohammadi-Milasi F; Mahnam K; Shakhsi-Niaei M
    J Biomol Struct Dyn; 2021 Apr; 39(7):2526-2542. PubMed ID: 32242486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations.
    Pittock SJ; Reindl M; Achenbach S; Berger T; Bruck W; Konig F; Morales Y; Lassmann H; Bryant S; Moore SB; Keegan BM; Lucchinetti CF
    Mult Scler; 2007 Jan; 13(1):7-16. PubMed ID: 17294606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients.
    Derdelinckx J; Nkansah I; Ooms N; Van Bruggen L; Emonds MP; Daniëls L; Reynders T; Willekens B; Cras P; Berneman ZN; Cools N
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.